Literature DB >> 27493455

Addition of Dexamethasone Alters the Bile Acid Composition by Inducing CYP8B1 in Primary Cultures of Human Hepatocytes.

Lisa-Mari Mörk1, Stephen C Strom2, Agneta Mode3, Ewa C S Ellis1.   

Abstract

BACKGROUND: Primary human hepatocytes offer the best human in vitro model for studies on human liver cell metabolism. Investigators use a variety of different media supplements and matrix biocoatings and the type of culture system used may influence the outcome.
OBJECTIVES: To optimize in vitro conditions for primary human hepatocytes with regard to bile acid synthesis.
METHODS: Human hepatocytes were isolated and cultured on collagen type I or EHS matrigel in cell media with or without dexamethasone. The glucocorticoid receptor (GR) antagonist RU486 was used to elucidate the involvement of GR.
RESULTS: Hepatocytes cultured on EHS matrigel produced more bile acids and expressed higher levels of cholesterol 7α-hydroxylase (CYP7A1) than cells cultured on rat tail collagen. Supplementation with dexamethasone increased the formation of cholic acid (CA) and decreased chenodeoxycholic acid formation. In line with these results, the mRNA expression of sterol 12α-hydroxylase (CYP8B1) increased following dexamethasone treatment. Surprisingly, the mRNA expression of CYP7A1 and CYP27A1 was not increased to the same extent. By using the GR antagonist RU486, we concluded that CYP8B1 induction is mediated via a GR-independent pathway. An altered expression of retinoid-related orphan receptor (ROR) α and ROR α target gene Glucose-6-phosphatase (G6Pase) suggests that ROR α signaling may regulate CYP8B1 expression.
CONCLUSION: Primary human hepatocytes have an increased bile acid synthesis rate when cultured on matrigel as compared to collagen. Exposure to glucocorticoid hormones stimulates the expression of CYP8B1, leading to an increased formation of CA and alteration of the bile acid composition. The effect is most likely mediated through a GR-independent pathway, possibly through ROR α.

Entities:  

Keywords:  BSEP, bile salt export pump; CA, cholic acid; CDCA, chenodeoxycholic acid; CYP27A1, sterol 27α-hydroxylase; CYP7A1, cholesterol 7α-hydroxylase; CYP8B1, sterol 12α-hydroxylase; FXR, farnesoid X receptor; G6Pase, glucose-6-phosphatase; GR, glucocorticoid receptor; NTCP, Na+-taurocholate cotransporting polypeptide; PXR, pregnane X receptor; ROR, retinoid-related orphan receptor; chenodeoxycholic acid; cholic acid; dexamethasone; matrigel; primary hepatocytes

Year:  2016        PMID: 27493455      PMCID: PMC4963319          DOI: 10.1016/j.jceh.2016.01.007

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  40 in total

1.  Bile acid synthesis in primary cultures of rat and human hepatocytes.

Authors:  E Ellis; B Goodwin; A Abrahamsson; C Liddle; A Mode; M Rudling; I Bjorkhem; C Einarsson
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

2.  Refinement of an in vitro cell model for cytochrome P450 induction.

Authors:  J M Silva; P E Morin; S H Day; B P Kennedy; P Payette; T Rushmore; J A Yergey; D A Nicoll-Griffith
Journal:  Drug Metab Dispos       Date:  1998-05       Impact factor: 3.922

3.  Bile acid secretion by cultured rat hepatocytes. Regulation by cholesterol availability.

Authors:  R A Davis; P M Hyde; J C Kuan; M Malone-McNeal; J Archambault-Schexnayder
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

Review 4.  Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics.

Authors:  Laura A Solt; Patrick R Griffin; Thomas P Burris
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

5.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

6.  Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor.

Authors:  Ewa Ellis; Magnus Axelson; Anna Abrahamsson; Gösta Eggertsen; Anders Thörne; Grzegorz Nowak; Bo-Göran Ericzon; Ingemar Björkhem; Curt Einarsson
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

7.  Glucocorticoid receptor-mediated upregulation of human CYP27A1, a potential anti-atherogenic enzyme.

Authors:  Wanjin Tang; Maria Norlin; Kjell Wikvall
Journal:  Biochim Biophys Acta       Date:  2008-09-10

8.  Bile acid synthesis in cultured human hepatoblastoma cells.

Authors:  M Axelson; B Mörk; G T Everson
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

9.  Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.

Authors:  Atul R Chopra; Jean-Francois Louet; Pradip Saha; Jie An; Franco Demayo; Jianming Xu; Brian York; Saul Karpen; Milton Finegold; David Moore; Lawrence Chan; Christopher B Newgard; Bert W O'Malley
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728

10.  Characteristics and regulation of bile salt synthesis and secretion by human hepatoma HepG2 cells.

Authors:  A D Cooper; W Y Craig; T Taniguchi; G T Everson
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

View more
  9 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet.

Authors:  Hong Lu; Xiaohong Lei; Rebecca Winkler; Savio John; Devendra Kumar; Wenkuan Li; Yazen Alnouti
Journal:  Lipids Health Dis       Date:  2022-05-25       Impact factor: 4.315

3.  Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System.

Authors:  Ujjal Sarkar; Kodihalli C Ravindra; Emma Large; Carissa L Young; Dinelia Rivera-Burgos; Jiajie Yu; Murat Cirit; David J Hughes; John S Wishnok; Douglas A Lauffenburger; Linda G Griffith; Steven R Tannenbaum
Journal:  Drug Metab Dispos       Date:  2017-04-27       Impact factor: 3.922

4.  Dexamethasone Pretreatment Alleviates Isoniazid/Lipopolysaccharide Hepatotoxicity: Inhibition of Inflammatory and Oxidative Stress.

Authors:  Hozeifa M Hassan; Hongli Guo; Bashir A Yousef; Ding Ping-Ping; Luyong Zhang; Zhenzhou Jiang
Journal:  Front Pharmacol       Date:  2017-03-15       Impact factor: 5.810

5.  Investigating the CYP2E1 Potential Role in the Mechanisms Behind INH/LPS-Induced Hepatotoxicity.

Authors:  Hozeifa M Hassan; Bashir A Yousef; Hongli Guo; Liu Xiaoxin; Luyong Zhang; Zhenzhou Jiang
Journal:  Front Pharmacol       Date:  2018-03-07       Impact factor: 5.810

6.  Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo.

Authors:  Nikolaos Nikolaou; Anastasia Arvaniti; Nathan Appanna; Anna Sharp; Beverly A Hughes; Dena Digweed; Martin J Whitaker; Richard Ross; Wiebke Arlt; Trevor M Penning; Karen Morris; Sherly George; Brian G Keevil; Leanne Hodson; Laura L Gathercole; Jeremy W Tomlinson
Journal:  J Endocrinol       Date:  2020-05       Impact factor: 4.286

Review 7.  The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis.

Authors:  Taylor Phelps; Erin Snyder; Erin Rodriguez; Hailey Child; Pamela Harvey
Journal:  Biol Sex Differ       Date:  2019-11-27       Impact factor: 5.027

8.  A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity.

Authors:  Chitra Saran; Dong Fu; Henry Ho; Abigail Klein; John K Fallon; Paavo Honkakoski; Kim L R Brouwer
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

9.  Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.

Authors:  Daniela Gabbia; Luisa Pozzo; Giorgia Zigiotto; Marco Roverso; Diana Sacchi; Arianna Dalla Pozza; Maria Carrara; Sara Bogialli; Annarosa Floreani; Maria Guido; Sara De Martin
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.